This pilot run is an important validation of our cell-free platform, demonstrating that it performs reliably at scale and delivers strong results in the hands of an external partner.” — Damien ...
LOS ANGELES, CA, UNITED STATES, March 18, 2026 /EINPresswire.com/ — Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) – a pioneer of AI-enhanced enzymes that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results